Cargando…

An Early Assessment of the Real-World Treatment Patterns of Type 2 Diabetes: A Comparison to the 2018 ADA/EASD Consensus Report Recommendations

INTRODUCTION: Using the American Diabetes Association (ADA) Hyperglycemic Pharmacotherapy Guidelines for type 2 diabetes, we evaluated the medication use patterns in real-world patients with type 2 diabetes in the USA. METHODS: Health care claims among patients with type 2 diabetes were analyzed (IB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Jay P., Kadziola, Zbigniew A., Liu, Dongju, Chinthammit, Chanadda, Boye, Kristina S., Mather, Kieren J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309104/ https://www.ncbi.nlm.nih.gov/pubmed/35764911 http://dx.doi.org/10.1007/s13300-022-01289-x

Ejemplares similares

Type 2 diabetes pharmacotherapy trends in high‐risk subgroups
por: Bae, Jay, et al.
Publicado: (2022)

Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus
por: Ibrahim, Mahmoud, et al.
Publicado: (2020)

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Davies, Melanie J., et al.
Publicado: (2018)

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Buse, John B., et al.
Publicado: (2020)

The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Holt, Richard I. G., et al.
Publicado: (2021)

Precision Medicine in Diabetes: A Consensus Report From the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Chung, Wendy K., et al.
Publicado: (2020)

Correction to: The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Holt, Richard I. G., et al.
Publicado: (2021)

Self-Mixed/Split Insulin Regimen: A Serious Omission in the ADA/EASD Position Statement
por: Davidson, Mayer B.
Publicado: (2014)

Management and prevention of cardiovascular disease for type 2 diabetes: Integrating the diabetes management recommendations of AACE, ADA, EASD, AHA, ACC, and ESC()
por: Bloomgarden, Zachary, et al.
Publicado: (2020)

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Davies, Melanie J., et al.
Publicado: (2022)

FRI639 Effect Of Early Initiation Of GLP-1 RAs On Weight Reduction Among People With Type 2 Diabetes
por: Chinthammit, Chanadda, et al.
Publicado: (2023)

Erratum. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020;43:487–493
por: Buse, John B., et al.
Publicado: (2020)

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
por: Schernthaner, G., et al.
Publicado: (2010)

Erratum to: Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
por: Schernthaner, G., et al.
Publicado: (2010)

Highlights vom EASD 2022
por: Stiefelhagen, Peter
Publicado: (2022)

Lead Management Consensus in 2018: From Recommendations to Research
por: Montgomery, Jay A., et al.
Publicado: (2018)

The changing landscape of scientific communication at EASD
por: Mathieu, Chantal, et al.
Publicado: (2022)

Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United States
por: Bajpai, Sanjay, et al.
Publicado: (2021)

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Inzucchi, Silvio E., et al.
Publicado: (2012)

Insulin Secretion Capacity as a Crucial Feature to Distinguish Type 1 From Type 2 Diabetes and to Indicate the Need for Insulin Therapy – A Critical Discussion of the ADA/EASD Consensus Statement on the Management of Type 1 Diabetes in Adults
por: Fritsche, Andreas
Publicado: (2023)

Abstracts of 52nd EASD Annual Meeting
Publicado: (2016)

Abstracts of the 49th Annual Meeting of the EASD
Publicado: (2013)

Diabetic Kidney Disease: A Report From an ADA Consensus Conference
por: Tuttle, Katherine R., et al.
Publicado: (2014)

Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
por: Inzucchi, SE, et al.
Publicado: (2013)

Reliable software technologies - ADA-Europe 2018: 23rd ADA-Europe international conference on reliable software technologies, Lisbon, Portugal, June 18-22, 2018, proceedings
por: Casimiro, António, et al.
Publicado: (2018)

57 (th) EASD Annual Meeting of the European Association for the Study of Diabetes
Publicado: (2021)

Weight management treatment modalities in patients with overweight or obesity: A retrospective cohort study of administrative claims data
por: Kan, Hong, et al.
Publicado: (2023)

The role for saxagliptin within the management of type 2 diabetes mellitus: an update from the 2010 European Association for the Study of Diabetes (EASD) 46th annual meeting and the American Diabetes Association (ADA) 70th scientific session
por: Aschner, Pablo J
Publicado: (2010)

Ada Lovelace
por: Jeapes, Ben, et al.
Publicado: (2019)

Ada Lovelace
por: Jeapes, Ben, et al.
Publicado: (2020)

Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline
por: Edelmann, Frank, et al.
Publicado: (2011)

Evaluation of a guided continuous quality improvement program in community pharmacies
por: Chinthammit, Chanadda, et al.
Publicado: (2017)

Ada-WHIPS: explaining AdaBoost classification with applications in the health sciences
por: Hatwell, Julian, et al.
Publicado: (2020)

EASD virtual meeting: European Association for the Study of Diabetes, September 21–25, 2020
por: Stuckey, Daniel W.
Publicado: (2020)

Comment on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
por: Rodbard, Helena W., et al.
Publicado: (2012)

Comment on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379
por: Giaccari, Andrea, et al.
Publicado: (2012)

Rendezvous with Ada 95
por: Naiditch, David, et al.
Publicado: (1995)

Software engineering with Ada
por: Booch, Grady, et al.
Publicado: (1994)

Ada for software engineers
por: Ben-Ari, M
Publicado: (1998)

Software engineering with ADA
por: Booch, Grady
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_b42bivnlbtqj9lvlohgac5qe1l